Cannabis in the News, Cannabis Market, Financial Results
22nd Century Group Reports Highlights and Financial Results for Q2 2022 22nd Century Group, Inc. (Nasdaq: XXII), a leading agricultural biotechnology company dedicated to improving human health with reduced nicotine tobacco, hemp/cannabis, and hops advanced plant...
Cannabis in the News, Expansion
22nd Century Group Enters South Korea 22nd Century Group, Inc. (Nasdaq: XXII), a leading agricultural biotechnology company focused on tobacco harm reduction, reduced nicotine tobacco, and improving health and wellness through modern plant science, today announced the...
Cannabis in the News, Finance, Investment Opportunities, marijuana stock, Stock Talk, Technical Analysis, Trending
22nd Century Group (Nasdaq: XXII) is a leading plant biotechnology company focused on technologies that alter the level of nicotine in tobacco plants and the level of cannabinoids in hemp/cannabis plants through genetic engineering, gene editing, and modern plant...